Position in LLY
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$600,944,465
-$824,914,261 QoQ
Shares Held
501,025
-67.7% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#124
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $2,878,468,803 across 10 Drug Manufacturers - General names. LLY ranks #1 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
501,025 | $600,944,465 | |
| 2 | ABBV |
AbbVie Inc.
|
2,097,882 | $527,911,026 | |
| 3 | JNJ |
Johnson & Johnson
|
1,939,364 | $492,540,275 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,702,992 | $347,334,472 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,287,888 | $289,051,769 | |
| 6 | PFE |
Pfizer Inc
|
11,902,374 | $286,609,165 | |
| 7 | AZN |
Astrazeneca PLC
|
1,352,177 | $256,399,802 | |
| 8 | AMGN |
Amgen Inc
|
191,247 | $69,254,363 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600,944,465 | 501,025 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $1,425,858,726 | 1,550,234 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $367,243,982 | 341,724 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $437,157,798 | 572,946 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,154,508,095 | 1,481,031 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $591,368,904 | 716,021 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $849,501,080 | 1,100,390 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $1,032,736,714 | 1,165,696 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $525,871,865 | 580,830 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $401,397,019 | 515,961 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $167,089,354 | 286,642 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $255,104,522 | 474,940 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $214,258,671 | 456,861 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $47,553,367 | 138,470 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $213,338,864 | 583,148 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $130,401,558 | 403,283 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $29,971,172 | 92,438 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $35,916,811 | 125,421 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $174,513,586 | 631,792 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $68,411,363 | 296,089 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $39,905,494 | 173,865 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $75,496,951 | 404,116 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $64,966,761 | 384,783 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $17,507,509 | 118,278 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $2,064,070 | 12,572 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $18,165,522 | 130,951 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||